https://clinicaltrials.gov/ct2/show/NCT03771885?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F02%2F2019&lupd_d=14
Condition : Lupus Erythematosus, Systemic
Interventions : Drug: BI 705564; Drug: Placebo
Sponsor : Boehringer Ingelheim
Not yet recruiting
BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)
NCT03771885
Tue, 11 Dec 2018 12:00:00 EST
>>> updated jan 8, 2019
